Federal Court Should Not Allow Further Delays in FDA Review of E-Cigarettes
WASHINGTON, D.C. – On May 15, U.S. District Judge Paul W.
WASHINGTON, D.C. – On May 15, U.S. District Judge Paul W.
Washington, D.C. – The American Cancer Society Cancer Action Network (ACS CAN) is launching a new initiative this week that will promote the experiences of cancer survivors in cancer-related policymaking.
Washington, D.C– June 11, 2019 – The U.S. Department of Veterans Affairs (DVA) announced yesterday that it will adopt a smoke-free policy for patients, visitors, contractors, volunteers and other vendors at all DVA health care facilities.
Washington, D.C. – Today Senate Majority Leader Mitch McConnell (R-Ky.) and Sen. Tim Kaine (D-Va.) introduced legislation that would raise the federal age of sale for tobacco products from 18 to 21.
Today the U.S. House of Representatives is expected to vote on a legislative package aimed at protecting and improving access to affordable health care and prescription drugs, including for those with serious pre-existing conditions like cancer.
WASHINGTON, D.C. – In a major victory for America’s kids and public health, a federal judge ruled Wednesday that, in August 2017, the U.S.
Today the Department of Health and Human Services (HHS) issued its final rule for Medicare Part D which does not include the full range of proposed changes to drugs in the ‘six protected classes’ of cancer, epilepsy, HIV/AIDS, mental illness and organ transplants.
The American Cancer Society Cancer Action Network (ACS CAN) launched an ad campaign this week highlighting deep concerns from cancer patients and survivors over the dangerous impact that proposed changes to Medicare Part D’s six protected classes could have on their access to critical drug therapies.
A new report issued today by the American Cancer Society Cancer Action Network (ACS CAN) shows people who enroll in short-term, limited duration (STLD) insurance plans are likely to face serious financial strain should they be diagnosed with cancer.
WASHINGTON, D.C. – Six leading public health and medical organizations today called on the U.S. Food and Drug Administration (FDA) to investigate and take enforcement action against Juul for making unauthorized claims that the company’s e-cigarettes help users stop smoking.